These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

897 related items for PubMed ID: 21751198

  • 1. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
    Fleming ND, Agadjanian H, Nassanian H, Miller CW, Orsulic S, Karlan BY, Walsh CS.
    Cancer; 2012 Feb 01; 118(3):689-97. PubMed ID: 21751198
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Nucleotide excision repair gene polymorphisms and risk of advanced colorectal adenoma: XPC polymorphisms modify smoking-related risk.
    Huang WY, Berndt SI, Kang D, Chatterjee N, Chanock SJ, Yeager M, Welch R, Bresalier RS, Weissfeld JL, Hayes RB.
    Cancer Epidemiol Biomarkers Prev; 2006 Feb 01; 15(2):306-11. PubMed ID: 16492920
    [Abstract] [Full Text] [Related]

  • 4. DNA repair genes XPC, XPG polymorphisms: relation to the risk of colorectal carcinoma and therapeutic outcome with Oxaliplatin-based adjuvant chemotherapy.
    Liu D, Wu HZ, Zhang YN, Kang H, Sun MJ, Wang EH, Yang XL, Lian MQ, Yu ZJ, Zhao L, Olopade OI, Wei MJ.
    Mol Carcinog; 2012 Oct 01; 51 Suppl 1():E83-93. PubMed ID: 22213216
    [Abstract] [Full Text] [Related]

  • 5. DNA repair gene associated with clinical outcome of epithelial ovarian cancer treated with platinum-based chemotherapy.
    Kang S, Sun HY, Zhou RM, Wang N, Hu P, Li Y.
    Asian Pac J Cancer Prev; 2013 Oct 01; 14(2):941-6. PubMed ID: 23621265
    [Abstract] [Full Text] [Related]

  • 6. [Polymorphisms in nucleotide excision repair genes XPC and XPD and clinical responses to platinum-based chemotherapy in advanced non-small cell lung cancer].
    Yuan P, Miao XP, Zhang XM, Wang ZH, Tan W, Sun Y, Xu BH, Lin DX.
    Zhonghua Yi Xue Za Zhi; 2005 Apr 13; 85(14):972-5. PubMed ID: 16061005
    [Abstract] [Full Text] [Related]

  • 7. Laryngeal cancer risk and common single nucleotide polymorphisms in nucleotide excision repair pathway genes ERCC1, ERCC2, ERCC3, ERCC4, ERCC5 and XPA.
    Lu B, Li J, Gao Q, Yu W, Yang Q, Li X.
    Gene; 2014 May 25; 542(1):64-8. PubMed ID: 24582975
    [Abstract] [Full Text] [Related]

  • 8. DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer.
    Kalikaki A, Kanaki M, Vassalou H, Souglakos J, Voutsina A, Georgoulias V, Mavroudis D.
    Clin Lung Cancer; 2009 Mar 25; 10(2):118-23. PubMed ID: 19362955
    [Abstract] [Full Text] [Related]

  • 9. Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.
    Gu J, Zhao H, Dinney CP, Zhu Y, Leibovici D, Bermejo CE, Grossman HB, Wu X.
    Clin Cancer Res; 2005 Feb 15; 11(4):1408-15. PubMed ID: 15746040
    [Abstract] [Full Text] [Related]

  • 10. SNP-SNP interactions between DNA repair genes were associated with breast cancer risk in a Korean population.
    Han W, Kim KY, Yang SJ, Noh DY, Kang D, Kwack K.
    Cancer; 2012 Feb 01; 118(3):594-602. PubMed ID: 21751184
    [Abstract] [Full Text] [Related]

  • 11. Nucleotide excision repair pathway genes and oral premalignant lesions.
    Wang Y, Spitz MR, Lee JJ, Huang M, Lippman SM, Wu X.
    Clin Cancer Res; 2007 Jun 15; 13(12):3753-8. PubMed ID: 17575242
    [Abstract] [Full Text] [Related]

  • 12. A Gynecologic Oncology Group study of platinum-DNA adducts and excision repair cross-complementation group 1 expression in optimal, stage III epithelial ovarian cancer treated with platinum-taxane chemotherapy.
    Darcy KM, Tian C, Reed E.
    Cancer Res; 2007 May 01; 67(9):4474-81. PubMed ID: 17483363
    [Abstract] [Full Text] [Related]

  • 13. Predictive effects of ERCC1 and XRCC3 SNP on efficacy of platinum-based chemotherapy in advanced NSCLC patients.
    Zhou C, Ren S, Zhou S, Zhang L, Su C, Zhang Z, Deng Q, Zhang J.
    Jpn J Clin Oncol; 2010 Oct 01; 40(10):954-60. PubMed ID: 20462983
    [Abstract] [Full Text] [Related]

  • 14. Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer.
    Xue MH, Li GY, Wu XJ, Zhang CX, Zhang CF, Zhu KX.
    Int J Clin Exp Pathol; 2015 Oct 01; 8(5):5563-9. PubMed ID: 26191265
    [Abstract] [Full Text] [Related]

  • 15. Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.
    Kim SH, Lee GW, Lee MJ, Cho YJ, Jeong YY, Kim HC, Lee JD, Hwang YS, Kim IS, Lee S, Oh SY.
    Lung Cancer; 2012 Sep 01; 77(3):578-84. PubMed ID: 22608006
    [Abstract] [Full Text] [Related]

  • 16. Potentially functional variants in the core nucleotide excision repair genes predict survival in Japanese gastric cancer patients.
    Li Y, Liu Z, Liu H, Wang LE, Onodera H, Suzuki A, Suzuki K, Wadhwa R, Elimova E, Sudo K, Shiozaki H, Estrella J, Lee JS, Song S, Tan D, Ajani JA, Wei Q.
    Carcinogenesis; 2014 Sep 01; 35(9):2031-8. PubMed ID: 24990617
    [Abstract] [Full Text] [Related]

  • 17. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
    Quintela-Fandino M, Hitt R, Medina PP, Gamarra S, Manso L, Cortes-Funes H, Sanchez-Cespedes M.
    J Clin Oncol; 2006 Sep 10; 24(26):4333-9. PubMed ID: 16896002
    [Abstract] [Full Text] [Related]

  • 18. Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis.
    Li C, Hu Z, Liu Z, Wang LE, Strom SS, Gershenwald JE, Lee JE, Ross MI, Mansfield PF, Cormier JN, Prieto VG, Duvic M, Grimm EA, Wei Q.
    Cancer Epidemiol Biomarkers Prev; 2006 Dec 10; 15(12):2526-32. PubMed ID: 17164380
    [Abstract] [Full Text] [Related]

  • 19. Single nucleotide polymorphisms in nucleotide excision repair genes XPA, XPD, XPG and ERCC1 in advanced colorectal cancer patients treated with first-line oxaliplatin/fluoropyrimidine.
    Monzo M, Moreno I, Navarro A, Ibeas R, Artells R, Gel B, Martinez F, Moreno J, Hernandez R, Navarro-Vigo M.
    Oncology; 2007 Dec 10; 72(5-6):364-70. PubMed ID: 18204222
    [Abstract] [Full Text] [Related]

  • 20. Inter-individual variation in nucleotide excision repair pathway is modulated by non-synonymous polymorphisms in ERCC4 and MBD4 genes.
    Allione A, Guarrera S, Russo A, Ricceri F, Purohit R, Pagnani A, Rosa F, Polidoro S, Voglino F, Matullo G.
    Mutat Res; 2013 Dec 10; 751-752():49-54. PubMed ID: 24004570
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.